Literature DB >> 23608327

Effect of WFDC 2 silencing on the proliferation, motility and invasion of human serous ovarian cancer cells in vitro.

Ya-Fei Zhu1, Guo-Lan Gao, Sheng-Bo Tang, Zhen-Dong Zhang, Qing-Shui Huang.   

Abstract

OBJECTIVE: To investigate effect and possible mechanisms of silencing human WFDC2 (HE4) gene on biological behavior changes as cell proliferation, apoptosis, movement and invasion of human serous ovarian cancer cell line SKOV3.
METHODS: Lentiviral WFDC2 gene sequence of small interfering siRNA was stablely transfected into SKOV3 identified by Q-PCR and western-blot. Obtained SKOV3 stable strains with silenced HE4 were measured by proliferation, apoptosis, migration, and invasion.
RESULTS: Gene sequencing showed that the oligonucleotides were successfully inserted into the expected site. After silencing HE4 in the SKOV3, proliferation was significantly inhibited (P<0.05). G(0)/G(1) phase was arrested by the cell cycle (P<0.01) and capacity of the migration and invasion decreased significantly (P<0.01). Slight early apoptosis ratio and no change of late apoptosis were found without change of Caspase-3 or Bcl-2 protein. Proteins involved in ERK pathway as phosphorylated protein as p-EGFR, p-ERK decreased and protease protein involved in tissue remodeling as matrix metalloproteinases MMP-9, MMP-2 and cathepsin B decreased compared with control group.
CONCLUSIONS: HE4 gene plays an important role in regulating proliferation, apoptosis, migration, invasion of serous ovarian cancer cells by ERK pathway and protease system. Its role in apoptosis needs to be further explored, and it may be a potential target for serous ovarian cancer.
Copyright © 2013 Hainan Medical College. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23608327     DOI: 10.1016/S1995-7645(13)60055-3

Source DB:  PubMed          Journal:  Asian Pac J Trop Med        ISSN: 1995-7645            Impact factor:   1.226


  10 in total

1.  YWHAE as an HE4 interacting protein can influence the malignant behaviour of ovarian cancer by regulating the PI3K/AKT and MAPK pathways.

Authors:  Xiao Li; Caixia Wang; Shuang Wang; Yuexin Hu; Shan Jin; Ouxuan Liu; Rui Gou; Xin Nie; Juanjuan Liu; Bei Lin
Journal:  Cancer Cell Int       Date:  2021-06-09       Impact factor: 5.722

2.  Human epididymis protein 4 in association with Annexin II promotes invasion and metastasis of ovarian cancer cells.

Authors:  Huiyu Zhuang; Mingzi Tan; Juanjuan Liu; Zhenhua Hu; Dawo Liu; Jian Gao; Liancheng Zhu; Bei Lin
Journal:  Mol Cancer       Date:  2014-11-01       Impact factor: 27.401

3.  Human Epididymis Protein 4 Promotes Events Associated with Metastatic Ovarian Cancer via Regulation of the Extracelluar Matrix.

Authors:  Jennifer R Ribeiro; Hilary M Gaudet; Mehreen Khan; Christoph Schorl; Nicole E James; Matthew T Oliver; Paul A DiSilvestro; Richard G Moore; Naohiro Yano
Journal:  Front Oncol       Date:  2018-01-22       Impact factor: 6.244

4.  Knockdown of HE4 suppresses aggressive cell growth and malignant progression of ovarian cancer by inhibiting the JAK/STAT3 pathway.

Authors:  Aihong Wang; Canhui Jin; Xiaoyu Tian; Ying Wang; Hongyu Li
Journal:  Biol Open       Date:  2019-09-02       Impact factor: 2.422

5.  The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes.

Authors:  Nicole E James; Jenna B Emerson; Ashley D Borgstadt; Lindsey Beffa; Matthew T Oliver; Virginia Hovanesian; Anze Urh; Rakesh K Singh; Rachael Rowswell-Turner; Paul A DiSilvestro; Joyce Ou; Richard G Moore; Jennifer R Ribeiro
Journal:  Sci Rep       Date:  2020-05-22       Impact factor: 4.379

Review 6.  The Proteolytic Landscape of Ovarian Cancer: Applications in Nanomedicine.

Authors:  Cailin O'Connell; Sabrina VandenHeuvel; Aparna Kamat; Shreya Raghavan; Biana Godin
Journal:  Int J Mol Sci       Date:  2022-09-01       Impact factor: 6.208

7.  HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells.

Authors:  J R Ribeiro; C Schorl; N Yano; N Romano; K K Kim; R K Singh; R G Moore
Journal:  J Ovarian Res       Date:  2016-05-17       Impact factor: 4.234

Review 8.  Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer.

Authors:  Nicole E James; Clinton Chichester; Jennifer R Ribeiro
Journal:  Front Oncol       Date:  2018-04-24       Impact factor: 6.244

9.  Lack of whey acidic protein (WAP) four-disulfide core domain protease inhibitor 2 (WFDC2) causes neonatal death from respiratory failure in mice.

Authors:  Kuniko Nakajima; Michio Ono; Uroš Radović; Selma Dizdarević; Shin-Ichi Tomizawa; Kazushige Kuroha; Go Nagamatsu; Ikue Hoshi; Risa Matsunaga; Takayuki Shirakawa; Takeyuki Kurosawa; Yasunari Miyazaki; Masahide Seki; Yutaka Suzuki; Haruhiko Koseki; Masataka Nakamura; Toshio Suda; Kazuyuki Ohbo
Journal:  Dis Model Mech       Date:  2019-11-12       Impact factor: 5.758

10.  Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer.

Authors:  Jorge A Alegría-Baños; José C Jiménez-López; Arely Vergara-Castañeda; David F Cantú de León; Alejandro Mohar-Betancourt; Delia Pérez-Montiel; Gisela Sánchez-Domínguez; Mariana García-Villarejo; César Olivares-Pérez; Ángel Hernández-Constantino; Acitlalin González-Santiago; Miguel Clara-Altamirano; Liz Arela-Quispe; Diddier Prada-Ortega
Journal:  J Ovarian Res       Date:  2021-07-19       Impact factor: 4.234

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.